Flyttr (formerly, Oxitec) - Dengue Control with Biological Mosquito Technologies

São Paulo, Brazil · Florida Keys, United States · 2011 · Flitrr (old Oxitec Ltd.)

Flitrr has fundamentally transformed vector control from an environmental hazard into a targeted bio-utility. Operationally, it eliminates the infrastructure, specialized transport fleets, and intense labor hours previously required to distribute live sterile insects. Politically and socially, by scaling non-GMO Wolbachia lines alongside their Friendly™ technology, they have successfully navigated complex biosafety frameworks and public skepticism surrounding genetic engineering. The systemic result is a permanent reduction in local viral transmission baselines (Dengue and Zika) across dense urban centers, creating a safe, sustainable template for climate-resilient city infrastructure.

Highlight

Urban dengue control at scale: targeted mosquito suppression, dengue-blocking Wolbachia replacement and AI-assisted deployment planning reduce reliance on chemical spraying.

Extended description

Context/Problem

Dengue and other mosquito-borne viral diseases are a growing urban public-health challenge, threatening billions of people globally, and the primary vectors - Aedes aegypti and Aedes albopictus - continue to expand in tropical, subtropical and temperate regions. Conventional management approaches, including chemical spraying and fogging, are increasingly constrained by insecticide resistance, operational complexity and the difficulty of reaching small breeding sites embedded across dense urban environments.

How the Solution Works

Flyttr offers complementary mosquito-based approaches to fight dengue, that work in different ways.  

Friendly™ Aedes is a genetically engineered population-suppression solution. It consists of safe, non-biting male Aedes aegypti mosquitoes carrying a self-limiting genetic trait. When these males mate with wild females, the trait is passed to the progeny and female offspring do not survive to become biting adults. Because female mosquitoes are the ones that bite and transmit disease, sustained releases reduce the local population of disease-transmitting mosquitoes over time. 

Sparks™ is complementary but different: it is not a genetically engineered mosquito solution, but is based on Wolbachia, a naturally occurring bacterium found in many insects. When Wolbachia is present in Aedes aegypti, it reduces the mosquito’s ability to transmit dengue, Zika, chikungunya and other arboviruses. Sparks™ therefore supports Wolbachia replacement: releasing Wolbachia-carrying mosquitoes so the trait can establish in local mosquito populations and reduce their capacity to spread disease.  

In simple terms, Friendly™ reduces the number of target mosquitoes, while Sparks™ makes the remaining mosquito population less able to transmit disease. 

Technologies/Processes & Operational Logic

The core operational innovation is Flyttr’s ability to turn advanced mosquito biology into a simple, scalable deployment system. Instead of relying on local adult mosquito rearing facilities and specialist handling teams, Flyttr’s model uses centrally manufactured mosquito eggs that can be shipped, stored and deployed on demand. The “just-add-water” concept is a core component of this operational model: mosquito eggs are supplied in compact deployment formats that can be activated with water at the point of use, allowing cities, professional distributors, field teams, or property owners to generate releases directly in the neighbourhoods where dengue risk is highest. 

This deployment approach applies to both Friendly™ Aedes and Sparks™ platforms. In both cases, the value lies in making the intervention operationally practical for city-scale public health campaigns. Because the model is built around shippable eggs rather than local rearing infrastructure, it transfers readily across geographies - from Brazilian municipalities to island communities in the Republic of the Marshall Islands, where Friendly™ Aedes is now serving communities, and to markets in the United States, Central America and elsewhere that are in approvals or pre-launch phase. 

Stakeholders & Systemic Implications

Flyttr’s model changes the operating approach to urban vector control. Conventional mosquito control is often organised as a centralised public service that reacts to outbreaks through area-wide pesticide spraying, fogging, larval-source removal and emergency campaigns. Flyttr instead creates a decentralised biological network: mosquito eggs are manufactured, distributed through public-sector and professional channels, and activated locally in the places where dengue risk is highest. This flips the system from a largely top-down chemical response into a targeted, distributed and data-informed form of urban public-health infrastructure. 

The stakeholder approach involves multiple sectors. Flyttr provides the biological platforms, large-scale manufacturing, deployment formats, monitoring systems and AI-enabled decision support. Municipal health departments and vector-control agencies define priority areas, integrate deployments into existing dengue-control workflows and track outcomes. Professional distributors, pest-management companies, employers, schools, transport hubs and other operators can extend coverage beyond what municipal teams can reach alone. Citizens and property owners participate by hosting just-add-water deployment boxes, turning backyards, workplaces and community spaces into part of the intervention network. 

This has important systemic implications for cities. Because Friendly™ and Sparks™ are species-specific biological tools, they can be deployed without the toxic chemical footprint associated with repeated insecticide spraying. Neither approach requires blanket chemical application across neighbourhoods, disruption of traffic, local, specialized manufacturing at point of use and the associated staff, infrastructure, water and electricity demands. The intervention is therefore more compatible with dense, mixed-use urban areas, environmentally sensitive settings, schools, transport hubs, tourism zones and workplaces. 

Extending the Platform Beyond Dengue 

The Friendly™ approach is part of a wider platform, and the progress made against Aedes aegypti is now being applied to other pest and vector species. The most advanced of these is Friendly™ Stephensi, targeting Anopheles stephensi - an invasive malaria vector that, unlike traditional rural malaria mosquitoes, thrives in urban water storage and construction sites and has been spreading rapidly across the Horn of Africa and beyond. Under a multi-year partnership announced with the Government of Djibouti in May 2022, a coalition led by the Djiboutian government is deploying Friendly™ Stephensi mosquitoes in Djibouti City to combat urban malaria, using the same egg-based deployment logic, community participation model and monitoring approach developed for dengue control. This shows that the manufacturing, regulatory and operational infrastructure built for Aedes aegypti can be redirected to new disease threats as they emerge, without the need to re-invent an entirely new control system.Demonstrated metrics

Demonstrated metrics

Real impact

Flyttr’s impact is a shift from reactive, broad-area chemical control toward targeted, biological and data-informed urban vector management. Its model allows cities to intervene at the source by suppressing local Aedes aegypti populations through Friendly™ releases, reducing vector competence through Sparks™ Wolbachia replacement, and using FlyttrMind to guide where and when interventions are needed.

In Brazil, this has moved beyond demonstration projects into routine public and commercial use. Aedes do Bem™ is serving governments, businesses and communities nationally through an established distribution network. Its deployable egg-based system allows biological control to be placed directly in urban environments where conventional tools are hardest to sustain.

The City of São Paulo partnership illustrates this transition at municipal scale. Large-scale Aedes do Bem™ deployment is being integrated into dengue-control operations, with areas selected using criteria including arbovirus incidence, population density, geography and socioeconomic vulnerability. FlyttrMind adds decision support by helping plan and optimize deployments using dengue-risk predictions down to household level, allowing resources to be directed toward higher-risk areas and interventions adjusted as risk changes.

The July 2026 approval of Flyttr’s Wolbachia-based mosquito solutions in Brazil adds a complementary dengue-control pathway. By authorising production and sale of professional Wolbachia supply, the approval creates a route for municipalities to procure Wolbachia replacement technology through Brazil’s National Arbovirus Control Program, expanding options to combine or sequence suppression and replacement approaches.

Beyond Brazil, Friendly™ Aedes is serving communities in the Republic of the Marshall Islands. In August 2024, the RMI Ministry of Health and Human Services began releases on Ebeye Island under the “Man Nam Ne” project. In Djibouti City, Friendly™ Stephensi is being deployed by a government-led coalition against Anopheles stephensi, demonstrating how the platform developed for dengue control can be adapted to another urban vector-borne disease.

Implementation location & date

Brazil is the principal deployment: Friendly™ Aedes was first deployed in 2011, with field deployment in Indaiatuba in 2019 and commercial launch in São Paulo in 2021; Aedes do Bem™ is now distributed nationally. In July 2026, ANVISA approved Flyttr’s Wolbachia-based mosquito solutions. Friendly™ Aedes is also deployed in the Republic of the Marshall Islands and in pre-launch or approval phases elsewhere, while Friendly™ Stephensi is being deployed in Djibouti City against urban malaria.

Similar cases elsewhere

Similar approaches include World Mosquito Program Wolbachia deployments in Indonesia, Australia and Brazil.